(Q39301083)

10 September 2017

Reduction of chemokine secretion in response to mycobacteria in infliximab-treated patients (English)

1 reference

10 September 2017

2

Sarah L Mackie

0 references

Robert J. Wilkinson

object named as

Robert J Wilkinson

9

0 references

Michael Levin

object named as

Michael Levin

8

0 references

Katalin A Wilkinson

4

object named as

Katalin A Wilkinson

1 reference

10 September 2017

Sandra M Newton

1

1 reference

10 September 2017

Sarah L Mackie

2

1 reference

10 September 2017

Adrian R Martineau

3

1 reference

10 September 2017

Beate Kampmann

5

1 reference

10 September 2017

Corinne Fisher

6

1 reference

10 September 2017

Shouma Dutta

7

1 reference

10 September 2017

Geoffrey Pasvol

10

1 reference

10 September 2017

26 December 2007

1 reference

Clinical and Vaccine Immunology

10 September 2017

1 reference

10 September 2017

15

1 reference

10 September 2017

3

1 reference

10 September 2017

506-512

1 reference

Mycobacterium abscessus infection after use of tumor necrosis factor alpha inhibitor therapy: case report and review of infectious complications associated with tumor necrosis factor alpha inhibitor use.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Tumor necrosis factor and granuloma biology: explaining the differential infection risk of etanercept and infliximab

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Clinical pharmacokinetics of TNF antagonists: how do they differ?

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Differences between anti-tumor necrosis factor-alpha monoclonal antibodies and soluble TNF receptors in host defense impairment.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Why does tumor necrosis factor targeted therapy reactivate tuberculosis?

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

TNF-blocking agents and tuberculosis: new drugs illuminate an old topic

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Serious infections associated with anticytokine therapies in the rheumatic diseases

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Chemokines and tuberculosis

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNF

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Cytokines and anti-cytokine biologicals in autoimmunity: present and future

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Immunology of tuberculosis

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

An increase in expression of a Mycobacterium tuberculosis mycolyl transferase gene (fbpB) occurs early after infection of human monocytes

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Restraining mycobacteria: role of granulomas in mycobacterial infections.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

The role of cytokines in the pathogenesis of rheumatoid arthritis

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Assessment of immunity to mycobacterial infection with luciferase reporter constructs.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Cytokine production of stimulated whole blood cultures in rheumatoid arthritis patients receiving short-term infliximab therapy

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Rapidly aggravated Mycobacterium avium infection in a patient with rheumatoid arthritis treated with infliximab.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Role of cellular activation and tumor necrosis factor-alpha in the early expression of Mycobacterium tuberculosis 85B mRNA in human alveolar macrophages

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

TNF influences chemokine expression of macrophages in vitro and that of CD11b+ cells in vivo during Mycobacterium tuberculosis infection

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Granulomatous infectious diseases associated with tumor necrosis factor antagonists

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Reactivation of latent tuberculosis infection in TNF-deficient mice

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Failure to control growth of mycobacteria in blood from children infected with human immunodeficiency virus and its relationship to T cell function

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268261

Antirheumatic drugs and the risk of tuberculosis

21 August 2018

1 reference

12 December 2020

Regulation of serum chemokines following infliximab therapy in patients with rheumatoid arthritis

1 reference

12 December 2020

Evaluation of Human Antimycobacterial Immunity Using Recombinant Reporter Mycobacteria

1 reference

12 December 2020

Chemokine networks in vivo: involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha

1 reference

12 December 2020

Mycobacterium fortuitum infection complicating infliximab therapy in rheumatoid arthritis

1 reference

12 December 2020

Tumor necrosis factor blockers and reactivation of latent tuberculosis

1 reference

12 December 2020

Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis

1 reference

12 December 2020

Tumor-necrosis-factor blockers: differential effects on mycobacterial immunity

1 reference

12 December 2020

Identifiers

DOI

10.1128/CVI.00401-07

1 reference

10 September 2017

1 reference

10 September 2017

1 reference